⌘K

Home/Filings/4/0001209191-17-050310

4//SEC Filing

Bonner Michael 4

Accession 0001209191-17-050310

CIK 0001087294other

View on SEC.gov Company Profile

Filed

Aug 24, 8:00 PM ET

Accepted

Aug 25, 4:57 PM ET

Size

4.4 KB

Accession

0001209191-17-050310

Insider Transaction Report

Form 4

Period: 2017-08-23

CUMBERLAND PHARMACEUTICALS INCCPIX

Chief Financial Officer

Transactions

Purchase
Common Stock
2017-08-23$6.72/sh+500$3,360→ 15,447 total

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

CUMBERLAND PHARMACEUTICALS INC

CIK 0001087294

Entity typeother

Related Parties

1

filerCIK 0001666790

Filing Metadata

Form type: 4
Filed: Aug 24, 8:00 PM ET
Accepted: Aug 25, 4:57 PM ET
Size: 4.4 KB

View on SEC.gov